Paysign, Inc. (NASDAQ:PAYS – Get Free Report) major shareholder Daniel Spence sold 100,000 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $3.60, for a total transaction of $360,000.00. Following the completion of the sale, the insider now owns 9,090,000 shares of the company’s stock, valued at approximately $32,724,000. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Paysign Stock Performance
Shares of NASDAQ PAYS traded up $0.02 during trading hours on Wednesday, hitting $3.67. The stock had a trading volume of 153,112 shares, compared to its average volume of 268,403. The firm’s 50-day moving average price is $4.54 and its two-hundred day moving average price is $4.39. Paysign, Inc. has a 52 week low of $1.67 and a 52 week high of $5.59. The company has a market capitalization of $194.16 million, a P/E ratio of 28.19 and a beta of 0.96.
Paysign (NASDAQ:PAYS – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.01 EPS for the quarter. The company had revenue of $14.33 million during the quarter, compared to the consensus estimate of $14.07 million. Paysign had a net margin of 14.42% and a return on equity of 32.55%. As a group, analysts expect that Paysign, Inc. will post 0.21 EPS for the current fiscal year.
Hedge Funds Weigh In On Paysign
Analyst Upgrades and Downgrades
Separately, Barrington Research reaffirmed an “outperform” rating and issued a $7.00 price target on shares of Paysign in a research note on Friday, June 28th.
View Our Latest Analysis on PAYS
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Featured Stories
- Five stocks we like better than Paysign
- Transportation Stocks Investing
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Upcoming IPO Stock Lockup Period, Explained
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- 3 Best Fintech Stocks for a Portfolio Boost
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.